{"transactions":[{"id":2717891,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary/CEO of subsidiary"}}],"security":"Restricted Stock Units","published_at":"2021-05-13T00:38:19.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":103500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":207000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":103500},"source":{"system":"sec-edgar","filing":"0001387131-21-005567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121005567/ownership.xml","form_type":"4"}},{"id":2717890,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary/CEO of subsidiary"}}],"security":"Common Stock","published_at":"2021-05-13T00:38:19.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":44252,"price":1.04,"value":46022.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations."}],"balance_after":1752703,"source":{"system":"sec-edgar","filing":"0001387131-21-005567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121005567/ownership.xml","form_type":"4"}},{"id":2717889,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary/CEO of subsidiary"}}],"security":"Common Stock","published_at":"2021-05-13T00:38:19.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":103500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021."}],"balance_after":1796955,"source":{"system":"sec-edgar","filing":"0001387131-21-005567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121005567/ownership.xml","form_type":"4"}},{"id":2805061,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Warrant (right to buy)","published_at":"2021-03-09T02:06:03.000Z","date":"2021-03-04","kind":"other","acquired":false,"shares":179000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant vested quarterly in eight equal installments commencing June 30, 2011, becoming fully-vested on March 31, 2013."}],"balance_after":0,"derivative":{"exercise_price":0.2444,"expiration_date":"2021-03-06","underlying":"Common Stock","underlying_shares":179000},"source":{"system":"sec-edgar","filing":"0001387131-21-003348","document":"milligan-form4_030421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003348/milligan-form4_030421.xml","form_type":"4"}},{"id":2805060,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2021-03-09T02:06:03.000Z","date":"2020-06-05","kind":"gift","acquired":false,"shares":434814,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares were owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities were held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001387131-21-003348","document":"milligan-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003348/milligan-form4_030421.xml","form_type":"4"}},{"id":2805059,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2021-03-09T02:06:03.000Z","date":"2021-03-04","kind":"tax_withholding","acquired":false,"shares":29964,"price":1.46,"value":43747.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 4, 2021, the reporting person exercised a warrant to purchase 179,000 shares of issuer common stock for $0.2444 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 29,964 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 149,036 shares."}],"balance_after":1693455,"source":{"system":"sec-edgar","filing":"0001387131-21-003348","document":"milligan-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003348/milligan-form4_030421.xml","form_type":"4"}},{"id":2805058,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2021-03-09T02:06:03.000Z","date":"2021-03-04","kind":"other","acquired":true,"shares":179000,"price":0.2444,"value":43747.6,"ownership":{"direct":true},"balance_after":1723419,"source":{"system":"sec-edgar","filing":"0001387131-21-003348","document":"milligan-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003348/milligan-form4_030421.xml","form_type":"4"}},{"id":2965623,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Restricted Stock Units","published_at":"2020-11-27T22:05:23.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022."}],"balance_after":360000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001387131-20-010306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120010306/ownership.xml","form_type":"4"}},{"id":3190260,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Restricted Stock Units","published_at":"2020-04-02T00:33:48.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":310500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."}],"balance_after":310500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":310500},"source":{"system":"sec-edgar","filing":"0001387131-20-003593","document":"milligan-form4_033020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120003593/milligan-form4_033020.xml","form_type":"4"}},{"id":3190259,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Performance Stock Units","published_at":"2020-04-02T00:33:48.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":310500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":310500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":310500},"source":{"system":"sec-edgar","filing":"0001387131-20-003593","document":"milligan-form4_033020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120003593/milligan-form4_033020.xml","form_type":"4"}},{"id":3386985,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2019-10-29T21:03:15.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":72000,"price":2.75,"value":198000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the issuer's public offering."}],"balance_after":1544419,"source":{"system":"sec-edgar","filing":"0001387131-19-007990","document":"milligan-form4_102519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119007990/milligan-form4_102519.xml","form_type":"4"}},{"id":3386959,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2019-10-29T21:01:38.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":72000,"price":2.75,"value":198000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the issuer's public offering."}],"balance_after":1544419,"source":{"system":"sec-edgar","filing":"0001387131-19-007992","document":"milligan-form4_102519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119007992/milligan-form4_102519.xml","form_type":"4"}},{"id":3426477,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-31T01:49:27.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 133,334 shares on the first anniversary date of the grant, 133,333 shares on the second anniversary date of the grant, and 133,333 shares on the third anniversary date of the grant."}],"balance_after":400000,"derivative":{"exercise_price":2.73,"exercise_date":"2020-08-28","expiration_date":"2029-08-28","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001387131-19-006605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006605/ownership.xml","form_type":"4"}},{"id":3435574,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2019-08-19T20:56:26.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":10000,"price":2.93,"value":29300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.87 to $2.99, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended."}],"balance_after":3582373,"source":{"system":"sec-edgar","filing":"0001387131-19-006246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006246/ownership.xml","form_type":"4"}},{"id":3439564,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2019-08-14T20:32:28.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":15000,"price":3.16,"value":47400.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.14 to 3.19, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended."}],"balance_after":3572373,"source":{"system":"sec-edgar","filing":"0001387131-19-006150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006150/ownership.xml","form_type":"4"}},{"id":3725953,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-20T01:01:31.000Z","date":"2018-12-18","kind":"exercise","acquired":false,"shares":129127,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129127},"source":{"system":"sec-edgar","filing":"0001387131-18-006855","document":"milligan-form4_121718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/milligan-form4_121718.xml","form_type":"4"}},{"id":3725952,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-20T01:01:31.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":129127,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001387131-18-006855","document":"milligan-form4_121718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/milligan-form4_121718.xml","form_type":"4"}},{"id":3725951,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-20T01:01:31.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":129127,"price":3.637,"value":469634.899,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.53 to $3.735, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006855","document":"milligan-form4_121718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/milligan-form4_121718.xml","form_type":"4"}},{"id":3725950,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-20T01:01:31.000Z","date":"2018-12-18","kind":"exercise","acquired":true,"shares":129127,"price":0.1018,"value":13145.1286,"ownership":{"direct":true},"balance_after":1601546,"source":{"system":"sec-edgar","filing":"0001387131-18-006855","document":"milligan-form4_121718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/milligan-form4_121718.xml","form_type":"4"}},{"id":3725949,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-20T01:01:31.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":129000,"price":3.75,"value":483750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.87, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006855","document":"milligan-form4_121718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/milligan-form4_121718.xml","form_type":"4"}},{"id":3725948,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-20T01:01:31.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":129000,"price":0.1018,"value":13132.2,"ownership":{"direct":true},"balance_after":1601419,"source":{"system":"sec-edgar","filing":"0001387131-18-006855","document":"milligan-form4_121718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/milligan-form4_121718.xml","form_type":"4"}},{"id":3743070,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-07T01:01:21.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":258127,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001387131-18-006632","document":"milligan-form4_120418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006632/milligan-form4_120418.xml","form_type":"4"}},{"id":3743069,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-07T01:01:21.000Z","date":"2018-12-04","kind":"exercise","acquired":false,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":387127,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001387131-18-006632","document":"milligan-form4_120418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006632/milligan-form4_120418.xml","form_type":"4"}},{"id":3743068,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-07T01:01:21.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":129000,"price":4.57,"value":589530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.7, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006632","document":"milligan-form4_120418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006632/milligan-form4_120418.xml","form_type":"4"}},{"id":3743067,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-07T01:01:21.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":129000,"price":0.1018,"value":13132.2,"ownership":{"direct":true},"balance_after":1601419,"source":{"system":"sec-edgar","filing":"0001387131-18-006632","document":"milligan-form4_120418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006632/milligan-form4_120418.xml","form_type":"4"}},{"id":3743066,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-07T01:01:21.000Z","date":"2018-12-04","kind":"sale","acquired":false,"shares":129000,"price":4.978,"value":642162.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $5.18, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006632","document":"milligan-form4_120418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006632/milligan-form4_120418.xml","form_type":"4"}},{"id":3743065,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-07T01:01:21.000Z","date":"2018-12-04","kind":"exercise","acquired":true,"shares":129000,"price":0.1018,"value":13132.2,"ownership":{"direct":true},"balance_after":1601419,"source":{"system":"sec-edgar","filing":"0001387131-18-006632","document":"milligan-form4_120418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006632/milligan-form4_120418.xml","form_type":"4"}},{"id":3748568,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-01T01:01:25.000Z","date":"2018-11-29","kind":"exercise","acquired":false,"shares":129128,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":516127,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129128},"source":{"system":"sec-edgar","filing":"0001387131-18-006478","document":"milligan-form4_112818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006478/milligan-form4_112818.xml","form_type":"4"}},{"id":3748567,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-01T01:01:25.000Z","date":"2018-11-28","kind":"exercise","acquired":false,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":645255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001387131-18-006478","document":"milligan-form4_112818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006478/milligan-form4_112818.xml","form_type":"4"}},{"id":3748566,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-01T01:01:25.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":129128,"price":5.034,"value":650030.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $5.095, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006478","document":"milligan-form4_112818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006478/milligan-form4_112818.xml","form_type":"4"}},{"id":3748565,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-01T01:01:25.000Z","date":"2018-11-29","kind":"exercise","acquired":true,"shares":129128,"price":0.1018,"value":13145.2304,"ownership":{"direct":true},"balance_after":1601547,"source":{"system":"sec-edgar","filing":"0001387131-18-006478","document":"milligan-form4_112818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006478/milligan-form4_112818.xml","form_type":"4"}},{"id":3748564,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-01T01:01:25.000Z","date":"2018-11-28","kind":"sale","acquired":false,"shares":129000,"price":4.886,"value":630294.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.765 to $5.065, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006478","document":"milligan-form4_112818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006478/milligan-form4_112818.xml","form_type":"4"}},{"id":3748563,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-12-01T01:01:25.000Z","date":"2018-11-28","kind":"exercise","acquired":true,"shares":129000,"price":0.1018,"value":13132.2,"ownership":{"direct":true},"balance_after":1601419,"source":{"system":"sec-edgar","filing":"0001387131-18-006478","document":"milligan-form4_112818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006478/milligan-form4_112818.xml","form_type":"4"}},{"id":3762813,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-17T01:02:12.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":774255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001387131-18-006314","document":"milligan-form4_111418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006314/milligan-form4_111418.xml","form_type":"4"}},{"id":3762812,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-17T01:02:12.000Z","date":"2018-11-14","kind":"exercise","acquired":false,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":903255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":129000},"source":{"system":"sec-edgar","filing":"0001387131-18-006314","document":"milligan-form4_111418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006314/milligan-form4_111418.xml","form_type":"4"}},{"id":3762811,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-11-17T01:02:12.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":129000,"price":4.989,"value":643581.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.78 to $5.11, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006314","document":"milligan-form4_111418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006314/milligan-form4_111418.xml","form_type":"4"}},{"id":3762810,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-11-17T01:02:12.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":129000,"price":0.1018,"value":13132.2,"ownership":{"direct":true},"balance_after":1601419,"source":{"system":"sec-edgar","filing":"0001387131-18-006314","document":"milligan-form4_111418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006314/milligan-form4_111418.xml","form_type":"4"}},{"id":3762809,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-11-17T01:02:12.000Z","date":"2018-11-14","kind":"sale","acquired":false,"shares":129000,"price":4.819,"value":621651.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.65 to $5.015, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-006314","document":"milligan-form4_111418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006314/milligan-form4_111418.xml","form_type":"4"}},{"id":3762808,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-11-17T01:02:12.000Z","date":"2018-11-14","kind":"exercise","acquired":true,"shares":129000,"price":0.1018,"value":13132.2,"ownership":{"direct":true},"balance_after":1601419,"source":{"system":"sec-edgar","filing":"0001387131-18-006314","document":"milligan-form4_111418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006314/milligan-form4_111418.xml","form_type":"4"}},{"id":3783837,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-26T01:06:08.000Z","date":"2018-10-24","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1032255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-005637","document":"milligan-form4_102318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005637/milligan-form4_102318.xml","form_type":"4"}},{"id":3783836,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-26T01:06:08.000Z","date":"2018-10-23","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1157255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-005637","document":"milligan-form4_102318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005637/milligan-form4_102318.xml","form_type":"4"}},{"id":3783835,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-26T01:06:08.000Z","date":"2018-10-24","kind":"sale","acquired":false,"shares":125000,"price":5.37,"value":671250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.18 to $5.535, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-005637","document":"milligan-form4_102318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005637/milligan-form4_102318.xml","form_type":"4"}},{"id":3783834,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-26T01:06:08.000Z","date":"2018-10-24","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-005637","document":"milligan-form4_102318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005637/milligan-form4_102318.xml","form_type":"4"}},{"id":3783833,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-26T01:06:08.000Z","date":"2018-10-23","kind":"sale","acquired":false,"shares":125000,"price":5.33,"value":666250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.15 to $5.435, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-005637","document":"milligan-form4_102318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005637/milligan-form4_102318.xml","form_type":"4"}},{"id":3783832,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-26T01:06:08.000Z","date":"2018-10-23","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-005637","document":"milligan-form4_102318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005637/milligan-form4_102318.xml","form_type":"4"}},{"id":3793201,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-11T23:01:30.000Z","date":"2018-10-10","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1282255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-005414","document":"milligan-form4_100918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005414/milligan-form4_100918.xml","form_type":"4"}},{"id":3793200,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-11T23:01:30.000Z","date":"2018-10-09","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1407255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-005414","document":"milligan-form4_100918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005414/milligan-form4_100918.xml","form_type":"4"}},{"id":3793199,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-11T23:01:30.000Z","date":"2018-10-10","kind":"sale","acquired":false,"shares":125000,"price":5.757,"value":719625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.4 to $6, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-005414","document":"milligan-form4_100918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005414/milligan-form4_100918.xml","form_type":"4"}},{"id":3793198,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-11T23:01:30.000Z","date":"2018-10-10","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-005414","document":"milligan-form4_100918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005414/milligan-form4_100918.xml","form_type":"4"}},{"id":3793197,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-11T23:01:30.000Z","date":"2018-10-09","kind":"sale","acquired":false,"shares":125000,"price":5.945,"value":743125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.81 to $5.995, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-005414","document":"milligan-form4_100918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005414/milligan-form4_100918.xml","form_type":"4"}},{"id":3793196,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-10-11T23:01:30.000Z","date":"2018-10-09","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-005414","document":"milligan-form4_100918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005414/milligan-form4_100918.xml","form_type":"4"}},{"id":3807018,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-27T23:02:30.000Z","date":"2018-09-26","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1532255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-005028","document":"milligan-form4_092518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005028/milligan-form4_092518.xml","form_type":"4"}},{"id":3807017,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-27T23:02:30.000Z","date":"2018-09-25","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1657255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-005028","document":"milligan-form4_092518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005028/milligan-form4_092518.xml","form_type":"4"}},{"id":3807016,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-27T23:02:30.000Z","date":"2018-09-26","kind":"sale","acquired":false,"shares":125000,"price":6.776,"value":847000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.7 to $6.88, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-005028","document":"milligan-form4_092518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005028/milligan-form4_092518.xml","form_type":"4"}},{"id":3807015,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-27T23:02:30.000Z","date":"2018-09-26","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-005028","document":"milligan-form4_092518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005028/milligan-form4_092518.xml","form_type":"4"}},{"id":3807014,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-27T23:02:30.000Z","date":"2018-09-25","kind":"sale","acquired":false,"shares":125000,"price":6.778,"value":847250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $6.885, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-005028","document":"milligan-form4_092518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005028/milligan-form4_092518.xml","form_type":"4"}},{"id":3807013,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-27T23:02:30.000Z","date":"2018-09-25","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-005028","document":"milligan-form4_092518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005028/milligan-form4_092518.xml","form_type":"4"}},{"id":3819152,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-13T00:19:40.000Z","date":"2018-09-11","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1782255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819151,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-13T00:19:40.000Z","date":"2018-09-10","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1907255,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819150,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-13T00:19:40.000Z","date":"2018-08-23","kind":"gift","acquired":true,"shares":434814,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"By the Milligan Irrevocable Nonexempt Trust - 2014. These securities are held in a trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":434814,"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819149,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-13T00:19:40.000Z","date":"2018-08-23","kind":"gift","acquired":false,"shares":434814,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"By the Reporting Person's Grantor-Retained Annuity Trust (the \"GRAT\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819148,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-13T00:19:40.000Z","date":"2018-09-11","kind":"sale","acquired":false,"shares":125000,"price":6.126,"value":765750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.03 to $6.22, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819147,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-13T00:19:40.000Z","date":"2018-09-11","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819146,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-13T00:19:40.000Z","date":"2018-09-10","kind":"sale","acquired":false,"shares":125000,"price":6.065,"value":758125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.245, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1472419,"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3819145,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-09-13T00:19:40.000Z","date":"2018-09-10","kind":"exercise","acquired":true,"shares":125000,"price":0.1018,"value":12725.0,"ownership":{"direct":true},"balance_after":1597419,"source":{"system":"sec-edgar","filing":"0001387131-18-004676","document":"milligan-form4_091018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004676/milligan-form4_091018.xml","form_type":"4"}},{"id":3991458,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-19T21:37:25.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 90,000 shares on the first anniversary date of the grant, 90,000 shares on the second anniversary date of the grant, and 90,000 shares on the third anniversary date of the grant."}],"balance_after":270000,"derivative":{"exercise_price":5.16,"exercise_date":"2019-03-15","expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001387131-18-001119","document":"milligan-form4_031518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118001119/milligan-form4_031518.xml","form_type":"4"}},{"id":4067893,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-02-13T02:18:37.000Z","date":"2017-11-29","kind":"gift","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 317,127 shares of common stock previously reported as being held indirectly by the GRAT."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended."}],"balance_after":2987523,"source":{"system":"sec-edgar","filing":"0001387131-18-000566","document":"milligan-form5_123117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118000566/milligan-form5_123117.xml","form_type":"5"}},{"id":4067892,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Common Stock","published_at":"2018-02-13T02:18:37.000Z","date":"2017-03-02","kind":"gift","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended."}],"balance_after":2690396,"source":{"system":"sec-edgar","filing":"0001387131-18-000566","document":"milligan-form5_123117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118000566/milligan-form5_123117.xml","form_type":"5"}},{"id":4381757,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":139532,"kind":"person","name":"Milligan John C.K. IV","position":1,"cik":"0001532230","reported_name":"Milligan John C.K. IV","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/Secretary"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2017-03-17T22:41:14.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 86,667 shares on the first anniversary date of the grant, 86,667 shares on the second anniversary date of the grant, and 86,666 shares on the third anniversary date of the grant."}],"balance_after":260000,"derivative":{"exercise_price":6.83,"exercise_date":"2018-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001387131-17-001465","document":"milligan-form4_031517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117001465/milligan-form4_031517.xml","form_type":"4"}}]}